(Q36086202)

12 August 2017

Recurrent versus non-recurrent or no eye involvement in Behcet's disease (English)

1 reference

12 August 2017

0 references

Toshihiko Matsuo

1

1 reference

PubMed ID

15804773

12 August 2017

Masako Itami

series ordinal

2

1 reference

12 August 2017

1 February 2005

1 reference

Ocular Immunology and Inflammation

12 August 2017

1 reference

12 August 2017

13

1 reference

12 August 2017

1

1 reference

12 August 2017

73-77

1 reference

Choroidal abnormalities in Behçet disease observed by simultaneous indocyanine green and fluorescein angiography with scanning laser ophthalmoscopy

12 August 2017

1 reference

https://api.crossref.org/works/10.1080%2F09273940490518928

The incidence and pathology of conjunctival ulceration in Behçet's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09273940490518928

Risk factor assessment and prognosis of eye involvement in Behcet's disease in Turkey.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09273940490518928

The long-term mortality and morbidity of Behçet syndrome: a 2-decade outcome survey of 387 patients followed at a dedicated center

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09273940490518928

Treatment and visual prognosis in Behçet's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09273940490518928

High dose intravenous steroid therapy for severe posterior segment uveitis in Behçet's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09273940490518928

Effectiveness of cyclosporin therapy for Behçet's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09273940490518928

Azathioprine in Behcet's syndrome: effects on long-term prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09273940490518928

Interferon alfa-2a in the treatment of Behçet disease: a randomized placebo-controlled and double-blind study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09273940490518928

Central nervous system symptoms in patients with Behçet disease receiving cyclosporine therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09273940490518928

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09273940490518928

10.1080/09273940490518928

21 January 2018

Identifiers

DOI

1 reference

12 August 2017

1 reference

PubMed ID

15804773